Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine for Brazilian Visceral Leishmaniasis
NCT00378495Phase 2Terminated
- Sponsor
- The A.B. Foundation for Medical Research
- Start
- Apr 2005
- Primary completion
- Apr 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine in visceral leishmaniasis (VL), sponsored by The A.B. Foundation for Medical Research. Started Apr 2005; status: terminated.
02
Drugs
miltefosine
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00378495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378495.